Company intelligence / Profile preview

Arsenal Bridge Ventures

Ownership: Private
Development stage: Other

Overview

Arsenal Bridge Ventures sources and invests in elite biotechnology innovations from mid-continent U.S. research universities with underdeveloped commercial networks. The firm focuses on building and scaling biotech companies through leadership recruitment, capital deployment, and syndication strategies to optimize asset value.

Therapeutic areas: Other
Modalities: Not applicable (investor, not a therapeutics developer)
Industry: Investors

Partnerships

Research Bridge Partners

Beyond the preview

Go deeper on Arsenal Bridge Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arsenal Bridge Ventures.

Explore the full profile